Vincere Biosciences Alternatives & Competitors
12 companies similar to Vincere Biosciences — Relentless pursuit of therapeutics that slow/stop the progression of age-related...
Companies similar to Vincere Biosciences
Cognition Therapeutics, Inc.
Advancing Accessible Solutions for Complex Neurodegenerative Diseases
EOLO PHARMA
Cutting-Edge Pharmacological Treatment for Obesity
Wren Therapeutics
Stopping the wave of neurodegeneration at its source
Pretzel Therapeutics
Welcome to a new era in mitochondrial therapeutics
Rival Readout
Competing with Vincere Biosciences? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Samsara Therapeutics
Treating Neurodegenerative Disease by Restoring Autophagy
Senexis Limited
Small-molecule therapies targeting amyloid protein toxicity
Vertero Therapeutics, Inc.
Pioneering science beyond the brain to treat neurodegenerative diseases at their source
OrganoTherapeutics
Using Midbrain Organoids for the development of new Therapeutics against Parkinson`s Disea...
Lento Bio
Restoring Tissue Flexibility and Function in Chronic Diseases of Aging
Elixir Pharmaceuticals
Pioneering the future of metabolic disease treatment by harnessing genetic interactions to...
About Vincere Biosciences
Vincere Biosciences, founded in 2018 and headquartered in the United States, is innovatively tackling age-related diseases through biotechnology. The company's mantra, "Relentless pursuit of therapeutics that slow/stop the progression of age-related disease," encapsulates its mission to revolutionize treatment paradigm...
Developing medicines for age-related diseases, Innovative drug discovery using virtual cell technology, Pre-clinical and clinical trial progression, Partnership development with pharmaceutical companies
Pharmaceutical companies, Healthcare professionals, Patients with age-related diseases, Research organizations interested in genetics and cellular biology
Pharmaceuticals, Small Molecule Therapeutics, Age-Related Diseases, Parkinson's Disease, Mitochondrial Quality Control, Mitophagy, Drug Discovery, Computational Tools, Mitochondrial Biogenesis, Disease Progression Modulation, Therapeutic Development, Neurodegenerative Diseases, Biomedical Research, JLABS Incubator
B2B, White Label
Licensing, Performance Based, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Vincere Biosciences: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Vincere Biosciences on 15 Jun 2026. The 12 companies listed here were last checked between 21 Jun 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.